• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of manufacturing techniques for adenovirus production.腺病毒生产的制造技术比较。
Cytotechnology. 1999 Jul;30(1-3):169-72. doi: 10.1023/A:1008040221630.
2
Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.在搅拌罐式反应器中建立水貂肠炎疫苗生产工艺,并在1-10升规模的波浪生物反应器微载体培养中进行。
Vaccine. 2007 May 16;25(20):3987-95. doi: 10.1016/j.vaccine.2007.02.061. Epub 2007 Mar 12.
3
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.一种在完全无动物成分条件下于搅拌式生物反应器中培养的Vero细胞中增殖狂犬病病毒的微载体细胞培养工艺。
Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5.
4
Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.使用BHK - 21细胞和化学成分确定的无蛋白培养基,对膜曝气搅拌罐和高达1000升气升式生物反应器中的生产工艺进行比较。
Biotechnol Prog. 2003 May-Jun;19(3):833-43. doi: 10.1021/bp0257630.
5
Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.在含血清和无血清培养基中,采用波浪式微载体培养MDCK细胞用于流感病毒生产。
Vaccine. 2006 Aug 28;24(35-36):6074-87. doi: 10.1016/j.vaccine.2006.05.023. Epub 2006 Jun 2.
6
Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.在一次性垂直轮生物反应器系统中生产溶瘤腺病毒和人间充质干细胞:生物反应器设计对基于微载体的细胞培养过程性能的影响。
Biotechnol Prog. 2015 Nov-Dec;31(6):1600-12. doi: 10.1002/btpr.2158. Epub 2015 Sep 4.
7
Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells.搅拌罐生物反应器培养结合无血清/无异种源培养基能够有效地扩增脐带间充质干/基质细胞。
Biotechnol J. 2016 Aug;11(8):1048-59. doi: 10.1002/biot.201500532. Epub 2016 Jun 13.
8
Monoterpenoid oxindole alkaloid production by Uncaria tomentosa (Willd) D.C. cell suspension cultures in a stirred tank bioreactor.在搅拌罐式生物反应器中,利用毛钩藤(Uncaria tomentosa (Willd) D.C.)细胞悬浮培养生产单萜吲哚生物碱
Biotechnol Prog. 2005 May-Jun;21(3):786-92. doi: 10.1021/bp049608s.
9
Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.在2升搅拌罐生物反应器中,在Cytodex 1微载体上生长的Vero细胞生产新城疫病毒。
J Biomed Biotechnol. 2010;2010:586363. doi: 10.1155/2010/586363. Epub 2010 Jun 10.
10
Transition from static culture to stirred tank bioreactor for the allogeneic production of therapeutic discogenic cell spheres.从静态培养向搅拌罐生物反应器转变,用于同种异体治疗性椎间盘细胞球体的生产。
Stem Cell Res Ther. 2021 Aug 12;12(1):455. doi: 10.1186/s13287-021-02525-0.

引用本文的文献

1
Integrating Affinity Chromatography in the Platform Process for Adenovirus Purification.将亲和色谱法整合到腺病毒纯化的平台工艺中。
Biotechnol Bioeng. 2025 Jul;122(7):1780-1792. doi: 10.1002/bit.29006. Epub 2025 Apr 22.
2
High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes.用于 COVID-19 疫苗接种的、在搅拌式一次性生物反应器中于 HEK 293 细胞中进行的高滴度重组腺病毒 26 载体的 GMP 生产。
ACS Omega. 2023 Oct 2;8(40):36720-36728. doi: 10.1021/acsomega.3c03007. eCollection 2023 Oct 10.
3
microRNA-181a silencing by antisense oligonucleotides delivered by virus-like particles.通过病毒样颗粒递送来沉默 microRNA-181a。
J Mater Chem B. 2023 Jan 25;11(4):816-825. doi: 10.1039/d2tb02199d.
4
Cell confluency analysis on microcarriers by micro-flow imaging.通过微流成像对微载体上的细胞汇合度进行分析。
Cytotechnology. 2016 Dec;68(6):2469-2478. doi: 10.1007/s10616-016-9967-0. Epub 2016 May 14.
5
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses.将溶瘤病毒推向临床:多种溶瘤病毒的临床级生产、纯化和鉴定。
Mol Ther Methods Clin Dev. 2016 Apr 6;3:16018. doi: 10.1038/mtm.2016.18. eCollection 2016.
6
Production of adenovirus vectors and their use as a delivery system for influenza vaccines.腺病毒载体的生产及其作为流感疫苗传递系统的应用。
Expert Opin Biol Ther. 2010 Oct;10(10):1469-87. doi: 10.1517/14712598.2010.519332.
7
Cell culture processes for the production of viral vectors for gene therapy purposes.用于基因治疗目的的病毒载体生产的细胞培养工艺。
Cytotechnology. 2006 Mar;50(1-3):141-62. doi: 10.1007/s10616-005-5507-z. Epub 2006 Jun 30.
8
Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells.开发和改进使用 HEK293 细胞生产重组腺病毒载体的无血清悬浮工艺。
Cytotechnology. 2001 Nov;37(3):189-98. doi: 10.1023/A:1020555310558.

本文引用的文献

1
Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies.采用补料分批策略,利用人腺病毒/293S表达系统提高重组蛋白产量。
Biotechnol Bioeng. 1996 Sep 20;51(6):613-23. doi: 10.1002/(SICI)1097-0290(19960920)51:6<613::AID-BIT1>3.0.CO;2-K.
2
Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells.用于在人293S细胞中生产重组蛋白的腺病毒表达系统的放大。
Cytotechnology. 1994;15(1-3):145-55. doi: 10.1007/BF00762389.
3
Transfer of genes to humans: early lessons and obstacles to success.基因向人类的转移:早期经验教训与成功面临的障碍
Science. 1995 Oct 20;270(5235):404-10. doi: 10.1126/science.270.5235.404.
4
Optimization of environment for high density Vero cell culture: effect of dissolved oxygen and nutrient supply on cell growth and changes in metabolites.高密度Vero细胞培养环境的优化:溶解氧和营养供应对细胞生长及代谢物变化的影响
J Cell Sci. 1986 Mar;81:65-103. doi: 10.1242/jcs.81.1.65.
5
An adenovirus type 5 early gene function regulates expression of other early viral genes.
Proc Natl Acad Sci U S A. 1979 Aug;76(8):3665-9. doi: 10.1073/pnas.76.8.3665.

腺病毒生产的制造技术比较。

Comparison of manufacturing techniques for adenovirus production.

机构信息

BioReliance Corporation, 9900 Blackwell Road, Rockville, Maryland, 20850, USA.

出版信息

Cytotechnology. 1999 Jul;30(1-3):169-72. doi: 10.1023/A:1008040221630.

DOI:10.1023/A:1008040221630
PMID:19003366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3449954/
Abstract

We have compared three different production methods, which may be suitable for the large scale production of adenovirus vectors for human clinical trials. The procedures compared 293 cells adapted to suspension growth in serum-free medium in a stirred tank bioreactor, 293 cells on microcarriers in serum-containing medium in a stirred tank bioreactor, and 293 cells grown in standard tissue culture plasticware. With a given virus, yields varied between 2000 and 10,000 infectious units/cell. The stirred tank bioreactor routinely produced between 4000 and 7000 infectious units/cell when 293 cells were grown on microcarriers. The 293 cells adapted to suspension growth in serum-free medium in the same stirred tank bioreactor yielded between 2000 and 7000 infectious units/cell. Yields obtained from standard tissue culture plasticware were up to 10,000 infectious units/cell. Cell culture conditions were monitored for glucose consumption, lactate production, and ammonia accumulation. Glucose consumption and lactate accumulation correlated well with the cell growth parameters. Ammonia production does not appear to be significant. Based on virus yields, ease of operation and linear scalability, large-scale adenovirus production seems feasible using 293 cells (adapted to suspension/serum free medium or on microcarriers in serum containing medium) in a stirred tank bioreactor.

摘要

我们比较了三种不同的生产方法,这些方法可能适用于大规模生产用于人体临床试验的腺病毒载体。所比较的程序包括在搅拌罐生物反应器中悬浮生长于无血清培养基中的适应悬浮生长的 293 细胞、在含血清培养基中的微载体上的 293 细胞,以及在标准组织培养塑料器皿中生长的 293 细胞。对于给定的病毒,产率在 2000 到 10000 感染单位/细胞之间变化。当 293 细胞在微载体上生长时,搅拌罐生物反应器通常产生 4000 到 7000 感染单位/细胞。在相同的搅拌罐生物反应器中适应悬浮生长于无血清培养基中的 293 细胞产生 2000 到 7000 感染单位/细胞。从标准组织培养塑料器皿获得的产率高达 10000 感染单位/细胞。监测细胞培养条件的葡萄糖消耗、乳酸产生和氨积累。葡萄糖消耗和乳酸积累与细胞生长参数密切相关。氨的产生似乎并不显著。基于病毒产率、操作简便性和线性可扩展性,使用搅拌罐生物反应器中的 293 细胞(适应于悬浮/无血清培养基或含血清培养基中的微载体)似乎可以大规模生产腺病毒。